National University Corporation Kobe University;Osaka University
发明人:
申请号:
EP16814103.4
公开号:
EP3315599A1
申请日:
2016.05.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
A cancer vaccine that can be orally administered can be provided through the use of a transformed Bifidobacterium capable of expressing and displaying a WT1 protein. The WT1 protein expressed and displayed by the transformed Bifidobacterium is a protein covering most of a WT1 protein unlike a WT1 peptide vaccine restricted to a certain HLA. A cancer vaccine using the transformed Bifidobacterium as an active ingredient is applicable to patients of various HLA types.